Skip to content

Clinical trials

Phase 3 Body Weight trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Body Weight Phase: Phase 3 Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20062
20071
20081
20093
20102
20112
20124
20132
20151
20163
20181
20221
20252
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated7
Unknown status4
Not yet recruiting4
Active, not recruiting3
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
Amgen3
Isfahan University of Medical Sciences2
Par Pharmaceutical, Inc.2
Viking Therapeutics, Inc.2
Alkermes, Inc.1
AstraZeneca1
Bethesda General Hospital, Hoogeveen1
Biopolis S.L.1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Body Weight38
Obesity16
Overweight10
Diabetes Mellitus, Type 29
Weight Loss8
Cachexia4
Diabetes Mellitus4
Metabolic Diseases4
Anorexia3
Endocrine System Diseases3

Trials

Showing 51 to 38 of 38. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.